242 related articles for article (PubMed ID: 16762146)
41. Interstitial lung disease associated with anti-PM-Scl antibody: A single center experience.
Ussavarungsi K; Nugent K; Gerke AK; Krasowski MD; Tuetken RS; Lenert PS
Autoimmun Rev; 2019 Sep; 18(9):102355. PubMed ID: 31323356
[No Abstract] [Full Text] [Related]
42. Anti-polymyositis/Scl antibody-positive overlap syndrome of diffuse cutaneous systemic sclerosis, dermatomyositis, systemic lupus erythematosus, and antiphospholipid syndrome.
Saito S; Endo Y; Nishio M; Uchiyama A; Uehara A; Toki S; Yasuda M; Ishikawa O; Muro Y; Motegi SI
J Dermatol; 2022 Feb; 49(2):294-298. PubMed ID: 34730249
[TBL] [Abstract][Full Text] [Related]
43. [Undifferentiated connective tissue disease: clinical and serological profile of 578 patients followed for five years: disease course, prognosis and therapy].
Bodolay E; Szegedi G
Orv Hetil; 2002 Feb; 143(5):229-33. PubMed ID: 11875835
[TBL] [Abstract][Full Text] [Related]
44. Sclerodermatomyositis associated with severe arthritis.
Toll A; Monfort J; Benito P; Pujol RM
Dermatol Online J; 2004 Oct; 10(2):18. PubMed ID: 15530308
[TBL] [Abstract][Full Text] [Related]
45. Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy.
Kao AH; Lacomis D; Lucas M; Fertig N; Oddis CV
Arthritis Rheum; 2004 Jan; 50(1):209-15. PubMed ID: 14730618
[TBL] [Abstract][Full Text] [Related]
46. [The PM-Scl (polymyositis-scleroderma) autoantibody and its nucleolar fluorescence pattern].
Kühn G; Jarzabek-Chorzelska M; Blaszczyk M; Kolacinska-Strasz Z; Chorzelski TP; Jablonska S
Dermatol Monatsschr; 1989; 175(8):479-83. PubMed ID: 2676628
[TBL] [Abstract][Full Text] [Related]
47. Polymyositis and the Spectrum of Scleroderma Disorders.
Cochicho J; Madaleno J; Louro E; Simão A; Carvalho A
Eur J Case Rep Intern Med; 2016; 3(1):000346. PubMed ID: 30755854
[TBL] [Abstract][Full Text] [Related]
48. [The shades of anti-Jo1 positive antisynthetase syndrome in a Hungarian cohort].
Szabó K; Nagy-Vincze M; Bodoki L; Hodosi K; Dankó K; Griger Z
Orv Hetil; 2016 Apr; 157(15):575-83. PubMed ID: 27039996
[TBL] [Abstract][Full Text] [Related]
49. The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Scl.
Marguerie C; Bunn CC; Copier J; Bernstein RM; Gilroy JM; Black CM; So AK; Walport MJ
Medicine (Baltimore); 1992 Nov; 71(6):327-36. PubMed ID: 1435228
[TBL] [Abstract][Full Text] [Related]
50. The changing landscape of the clinical value of the PM/Scl autoantibody system.
Mahler M; Fritzler MJ
Arthritis Res Ther; 2009; 11(2):106. PubMed ID: 19351430
[TBL] [Abstract][Full Text] [Related]
51. PM1-Alpha ELISA: the assay of choice for the detection of anti-PM/Scl autoantibodies?
Mahler M; Fritzler MJ
Autoimmun Rev; 2009 Mar; 8(5):373-8. PubMed ID: 19103309
[TBL] [Abstract][Full Text] [Related]
52. Autoantibodies directed to novel components of the PM/Scl complex, the human exosome.
Brouwer R; Vree Egberts WT; Hengstman GJ; Raijmakers R; van Engelen BG; Seelig HP; Renz M; Mierau R; Genth E; Pruijn GJ; van Venrooij WJ
Arthritis Res; 2002; 4(2):134-8. PubMed ID: 11879549
[TBL] [Abstract][Full Text] [Related]
53. Anti-Jo-1 antibody in patients with polymyositis/dermatomyositis.
Leu CC; Lan JL
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Feb; 25(1):41-7. PubMed ID: 1306148
[TBL] [Abstract][Full Text] [Related]
54. Childhood scleromyositis: an overlap syndrome associated with PM-Scl antibody.
Błaszczyk M; Jabłońska S; Szymańska-Jagiełło W; Jarzabek-Chorzelska M; Chorzelski T; Mohamed AH
Pediatr Dermatol; 1991 Mar; 8(1):1-8. PubMed ID: 1907368
[TBL] [Abstract][Full Text] [Related]
55. Fluoroenzymeimmunoassay to detect systemic sclerosis-associated antibodies: diagnostic performance and correlation with conventional techniques.
Bonroy C; Smith V; Van Steendam K; Van Praet J; Deforce D; Devreese K; De Keyser F
Clin Exp Rheumatol; 2012; 30(5):748-55. PubMed ID: 22765957
[TBL] [Abstract][Full Text] [Related]
56. Interstitial Lung Disease Is a Major Characteristic of Patients Who Test Positive for Anti-PM/Scl Antibody.
Ge Y; Shu X; He L; Li C; Lu X; Wang G
Front Med (Lausanne); 2021; 8():778211. PubMed ID: 35118087
[TBL] [Abstract][Full Text] [Related]
57. [The anti-synthetase syndrome].
Bergoin C; Bure M; Tavernier JY; Lamblin C; Maurage CA; Remy-Jardin M; Wallaert B
Rev Mal Respir; 2002 Jun; 19(3):371-4. PubMed ID: 12161705
[TBL] [Abstract][Full Text] [Related]
58. The human exosome: an autoantigenic complex of exoribonucleases in myositis and scleroderma.
Brouwer R; Pruijn GJ; van Venrooij WJ
Arthritis Res; 2001; 3(2):102-6. PubMed ID: 11178117
[TBL] [Abstract][Full Text] [Related]
59. Sera from anti-Jo-1-positive patients with polymyositis and interstitial lung disease induce expression of intercellular adhesion molecule 1 in human lung endothelial cells.
Barbasso Helmers S; Englund P; Engström M; Ahlin E; Fathi M; Janciauskiene S; Heimbürger M; Rönnelid J; Lundberg IE
Arthritis Rheum; 2009 Aug; 60(8):2524-30. PubMed ID: 19644880
[TBL] [Abstract][Full Text] [Related]
60. [Prevalence and diagnostic value of antinuclear antibodies without identified antigenic target: a retrospective study of 90 patients].
Feki S; Frikha F; Ben Hadj Hmida Y; Abed S; Ben Ayed M; Turki H; Hachicha J; Baklouti S; Bahloul Z; Masmoudi H
Rev Med Interne; 2012 Sep; 33(9):475-81. PubMed ID: 22658165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
